# Contrast Enhanced Ultrasound Imaging for Cerebral Perfusion Measurement in Cerebral Vasospasm After SAH

> **NCT02907879** · — · TERMINATED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 54 (actual)

## Conditions studied

- Subarachnoid Hemorrhage

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02907879
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-07
- **Primary completion:** 2021-01
- **Final completion:** 2021-04
- **Target enrollment:** 54 (ACTUAL)
- **Why stopped:** Insufficient recruitment
- **Last updated:** 2021-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02907879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02907879, "Contrast Enhanced Ultrasound Imaging for Cerebral Perfusion Measurement in Cerebral Vasospasm After SAH". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02907879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*